Hostname: page-component-6dbcb7884d-cm8hq Total loading time: 0 Render date: 2025-02-14T07:44:28.181Z Has data issue: false hasContentIssue false
  • English
  • Français

Differences in memory function between 5-HT1A receptor genotypes in patients with major depressive disorder

Published online by Cambridge University Press:  19 January 2016

Keith A. Wesnes ,
Seth C. Hopkins ,
Helen J. Brooker  and
Kenneth S. Koblan
Keith A. Wesnes*
Affiliation:
Wesnes Cognition Ltd., Streatley on Thames, UK Department of Psychology, Northumbria University, Newcastle, UK Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia
Seth C. Hopkins
Affiliation:
Global Translational Medicine & Early Development, Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA
Helen J. Brooker
Affiliation:
Wesnes Cognition Ltd., Streatley on Thames, UK
Kenneth S. Koblan
Affiliation:
Global Translational Medicine & Early Development, Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts, USA
*
*Address for correspondence: Professor K. A. Wesnes, Wesnes Cognition Ltd. Little Paddock, Streatley Hill, Streatley on Thames, RG8 9RD, UK. (Email: keith@wesnes.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

While extensive literature on the role of the serotonin receptor 1A (5-HT1A-R) in cognition exists, the findings are largely from animal studies. There has been little research conducted into 5-HT1A-R genotypes and cognitive function in humans. This article evaluates the role of 5-HT1A-R genotypes on the profile of cognitive function in patients with major depressive disorder (MDD).

Methods

The study sample was 455 MDD patients aged between 18 and 55 years. They had enrolled into a clinical trial and were tested prior to dosing on the baseline study day using the CDR System, an integrated set of 3 attention tests, 2 working memory tests, and 4 episodic memory tests. 5-HT1A-R genotyping for (SNP ID rs6295) had been conducted during the study screening period.

Results

Validated factor scores were derived from the 9 tests. It was found that patients with the C/C genotype for the C(1019)G polymorphism of the 5-HT1A-R were significantly superior in retaining and retrieving information, in both working and episodic memory, than those with either the C/G or the G/G genotypes. No differences were found in measures of attention or in the speed of retrieval of information from memory.

Conclusions

This is, to our knowledge, the first relationship found between objective tests of cognitive function and 5-HT1A-R genotypes in MDD.

Keywords

5-HT1A-Rcognitive functionCDR SystemgenotypesMDDmemory
Type
Original Research
Information
CNS Spectrums , Volume 21 , Issue 5 , October 2016 , pp. 379 - 384
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Buhot, MC, Martin, S, Segu, L. Role of serotonin in memory impairment. Ann Med. 2000; 32(3): 210–221.Google Scholar
2. Marazziti, D, Marracci, S, Palego, L, et al. Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res. 1994; 658(1–2): 55–59.Google Scholar
3. Yasuno, F, Suhara, T, Nakayama, T, et al. . Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. Am J Psychiatry. 2003; 160(2): 334–340.Google Scholar
4. Steckler, T, Sahgal, A. The role of serotonergic–cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res. 1995; 67(2): 165–199.Google Scholar
5. Meneses, A. 5-HT system and cognition. Neurosci Biobehav Rev. 1999; 23(8): 1111–1125.Google Scholar
6. Ogren, S, Eriksson, T, Elvander-Tottie, E, et al. The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res. 2008; 195(1): 54–77.Google Scholar
7. Savitz, J, Lucki, I, Drevets, WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009; 88(1): 17–31.Google Scholar
8. Drago, A, De Ronchi, D, Serretti, A. 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Int J Neuropsychopharmacol. 2008; 11(5): 701–721.Google Scholar
9. Kuffel, A, Eikelmann, S, Terfehr, K, et al. Noradrenergic blockade and memory in patients with major depression and healthy participants. Psychoneuroendocrinology. 2013; 40: 86–90.Google Scholar
10. Pehrson, AL, Sanchez, C.. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 2014; 19(2): 121–133.Google Scholar
11. Bosia, M, Anselmetti, S, Bechi, M, et al. Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia. Psychiatry Res. 2011; 188(2): 187–190.Google Scholar
12. Terzić, T, Kastelic, M, Dolžan, V, Plesničar, BK. Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia. Neuropsychiatr Dis Treat. 2015; 11: 453–459.Google Scholar
13. Albert, PR, Le François, B, Millar, AM. Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. Mol Brain. 2011; 4: 21.Google Scholar
14. Drevets, WC, Thase, ME, Moses-Kolko, EL, et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol. 2007; 34(7): 865–877.CrossRefGoogle ScholarPubMed
15. Boldrini, M, Underwood, MD, Mann, JJ, Arango, V . Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res. 2008; 42(6): 433–442.Google Scholar
16. Guy, W. ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976.Google Scholar
17. Sheehan, DV. The Sheehan Disability Scales. In. The Anxiety Disease and How to Overcome It. New York: Charles Scribner and Sons; 1983. 151.Google Scholar
18. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56–62.Google Scholar
19. Ferguson, JM, Wesnes, KA, Schwartz, GE. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol. 2003; 18(1): 9–14.Google Scholar
20. Reddy, S, Focht, K, Musgnung, J, Edgar, C, Gucio-Pabia, CJ, Wesnes, KA. The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder. Presented at the ISCTM Annual Meeting, October 13–14, 2010, Baltimore, MD. https://isctm.org/public_access/2010_13Oct_Posters_Abstracts.pdf.Google Scholar
21. Wesnes, KA, Ward, T, McGinty, A, Petrini, O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology (Berl). 2000; 152(4): 353–361.Google Scholar
22. Wesnes, KA, Luthringer, R, Ambrosetti, L, et al. The effects of a combination of Panax ginseng, vitamins and minerals on mental performance, mood and physical fatigue in nurses working night shifts: a double-blind, placebo controlled trial. Current Topics in Nutraceutical Research. 2003; 1: 169–174.Google Scholar
23. Wesnes, KA, Pincock, C. Practice effects on cognitive tasks: a major problem? Lancet Neurol. 2002; 1(8): 473.Google Scholar
24. Frey, PW, Colliver, JA. Sensitivity and responsiveness measures for discrimination learning. Learning and Motivation. 1973; 4(3): 327–342.Google Scholar
25. Albert, PR, Lemonde, S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 2004; 10(6): 575–593.CrossRefGoogle ScholarPubMed
26. Schatzberg, AF, Nemeroff, CB eds. The American Psychiatric Publishing Textbook of Psychopharmacology, 4th ed.. Washington, DC: American Psychiatric Publishing; 2009.Google Scholar
27. Miller, JM, Hesselgrave, N, Ogden, RT, et al. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry. 2013; 74(10): 760–776.Google Scholar
28. Parsey, RV, Olvet, DM, Oquendo, MA, et al. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006; 31(8): 1745–1749.Google Scholar
29. Meeter, M, Talamini, L, Schmitt, JAJ, Riedel, WJ. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology. 2006; 31(4): 712–720.Google Scholar
30. McIntyre, RS, Lophaven, S, Olsen, CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014; 17(10): 1557–1567.Google Scholar